This content is from: Premium These Hedge Funds Made Huge Bets on Moderna Several of the most well-known firms made savvy moves into the Covid-19 vaccine maker before the stock surged 75 percent. By Stephen Taub August 24, 2021
This content is from: Premium Perceptive Gets a Big Boost From Pfizer’s Array Deal The healthcare and biotech specialist enjoyed hefty gains in many of its top holdings on Monday. By Stephen Taub June 18, 2019
This content is from: Corner Office BlackRock’s Annual Stewardship Report Takes on Buffett, ExxonMobil, and Political Contributions Over the past year BlackRock voted on more than 13,000 companies and 165,000 management and shareholder proposals. By Michelle Celarier July 20, 2021
Sponsored Three Events Markets Will Be Watching as 2020 Comes to a Close Sponsored by CME Group November 30, 2020
This content is from: Portfolio Vaccines Have Arrived — And Investors Are Ready to Party Fund managers are the most bullish they’ve been all year, according to Bank of America’s monthly survey. By Amy Whyte December 15, 2020
This content is from: Premium Perceptive’s China Rx The life sciences giant is one of at least seven hedge funds that have invested in LianBio, scheduled to go public this week. Here’s why this IPO is different. By Stephen Taub October 25, 2021
